Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis
- 1 November 2021
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 237, 20-25
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Clinical Research Center for Mental Health (19MC1911100)
- School of Medicine, Shanghai Jiao Tong University
This publication has 24 references indexed in Scilit:
- Graphical Tools for Network Meta-Analysis in STATAPLOS ONE, 2013
- Consistency and inconsistency in network meta‐analysis: concepts and models for multi‐arm studiesResearch Synthesis Methods, 2012
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary StatementsSchizophrenia Bulletin, 2009
- Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of SchizophreniaNeuropsychopharmacology, 2009
- Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescentsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2009
- The Effect of Long-Term Antipsychotic Treatment on ProlactinJournal of Child and Adolescent Psychopharmacology, 2006
- Imputing missing standard deviations in meta-analyses can provide accurate resultsJournal of Clinical Epidemiology, 2006
- Prevalence of Hyperprolactinemia in SchizophreniaThe Journal of Clinical Psychiatry, 2004
- Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidonePsychoneuroendocrinology, 2003
- A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosisInternational Journal of Neuropsychopharmacology, 1999